MB-325 · Pharmaceuticals & Medical Devices · Healthcare & Life Sciences
SyngeneMegaBrand · CDMO and contract research
Syngene is the MegaBrand for CDMO and contract research in India in the 2026–27 MegaBrands 501 — WCRC's research benchmark of the most powerful market-facing brand in each of 501 categories. It was selected by research alone, measured in the same fieldwork and on the same 50 parameters as Piramal Pharma Solutions, Jubilant Biosys, Sai Life Sciences, Aragen and Anthem Biosciences.
- MegaBrand
- Syngene
- Category
- CDMO and contract research
- Industry
- Pharmaceuticals & Medical Devices
- Sector
- Healthcare & Life Sciences
- Market
- business (B2B)
- Edition
- MegaBrands 501, 2026–27 Founding Edition
- MegaBrand ID
- MB-325 (slot number, not a rank)
- In contention for
- Industry MegaBrand · Pharmaceuticals & Medical Devices; India's 100 Most Powerful Brands 2026–27
What it means
As the MegaBrand of CDMO and contract research, Syngene is the standard against which other brands in its category are measured in 2026–27. Its brand power is read across five pillars — positioning and recall, consumer trust and sentiment, product and delivery, sustainability and governance, and digital and financial soundness — and refreshed every quarter through the Consumer and Market Pulse from 1 November 2026.
How MegaBrands are selected → · Syngene on mostvaluablebrands.com →
Questions and answers
Which brand is the MegaBrand for CDMO and contract research in India?
Syngene is the MegaBrand for CDMO and contract research in the 2026–27 MegaBrands 501 by WCRC Intelligence.
Which brands were assessed alongside Syngene?
Piramal Pharma Solutions, Jubilant Biosys, Sai Life Sciences, Aragen and Anthem Biosciences were assessed alongside Syngene, in the same fieldwork and on the same 50 parameters.
Is Syngene in contention for India's 100 Most Powerful Brands?
Yes. Every brand in the 501 cohort, including Syngene, is in contention for Industry MegaBrand in Pharmaceuticals & Medical Devices and for India's 100 Most Powerful Brands 2026–27, announced on 18 March 2027.
Other MegaBrands in Pharmaceuticals & Medical Devices
- Sun PharmaGenerics and formulations — domestic
- Dr. Reddy'sGenerics and formulations — export and regulated markets
- CiplaSpecialty and branded prescription pharma
- Divi's LaboratoriesAPIs and intermediates
- BioconBiologics and biosimilars
- Serum Institute of IndiaVaccines and immunology
- Siemens Healthineers IndiaImaging and diagnostic equipment
- Meril Life SciencesSurgical devices and implants
- BPL Medical TechnologiesCritical care and patient monitoring
- 3M IndiaConsumables and disposables
- Carl Zeiss IndiaOphthalmic and vision equipment
How to cite
WCRC Intelligence, "Syngene — MegaBrand, CDMO and contract research", MegaBrands 501 (2026–27), https://www.wcrcint.com/megabrands-501/brand/syngene
Free to read and quote with attribution to WCRC Intelligence and a link to this page.